Showing results (211-220 of 344) with videos related to
Sort By:
Pageof 35
Scientific Reports|November 5, 2020
Regulatory (FoxP3+) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancerJiae Koh, Joon Young Hur, Kyoung Young Lee, et al.Cancer Research and Treatment|March 19, 2026
Phase II Efficacy and Safety of Pembrolizumab with Platinum Based Chemotherapy in Non-Small Cell Lung Cancer Patients with Untreated, Asymptomatic Brain Metastasis (PHOEBS)Junkyu Kim, Miran Han, Jinyong Kim, et al.Cancer Research and Treatment|July 28, 2018
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in KoreaSeonggyu Byeon, Youjin Kim, Sung Won Lim, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 10, 2024
Comparison of the treatment outcomes of different neoadjuvant chemoradiotherapy regimens for resectable locally advanced esophageal cancerHyunki Park, Kyungmi Yang, Jae Myoung Noh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2015
The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase InhibitorsJi Yun Lee, Bo Mi Ku, Sung Hee Lim, et al.Oncotarget|November 9, 2016
A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01)Hye Ryun Kim, Joung Soon Jang, Jong-Mu Sun, et al.BMC Cancer|May 24, 2012
ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapyJong-Mu Sun, Ji-Youn Sung, Se Hoon Park, et al.International Journal of Radiation Oncology, Biology, Physics|May 31, 2011
Expression of excision repair cross-complementation group 1 as predictive marker for nasopharyngeal cancer treated with concurrent chemoradiotherapyJong-Mu Sun, Myung-Ju Ahn, Min Jae Park, et al.JAMA Network Open|March 17, 2023
Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020Sang Ah Chi, Hyeyeon Yu, Yoon-La Choi, et al.Lung Cancer (Amsterdam, Netherlands)|May 15, 2012
Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?Jong-Mu Sun, Myung-Ju Ahn, Jin Seok Ahn, et al.Pageof 35